Bioplastics Market Size, Trends, Growth Status, Key Players Overview, Price Analysis, Share Estimation and Forecast to 2028 The global bioplastics market size is expected to experience exponential growth by reaching USD 15,552.3 million by 2028 while exhibiting a CAGR of 10.7% between 2021 and 2028. Fortune Business Insights in its latest report, titled, “Bioplastics Market, 2021-2028.”, mentions that the market stood at USD 7,043.9 million in 2020. Factors such as the increasing demand for eco-friendly plastics across packaging industry and the rising concerns over non-degradable plastic waste are expected to drive the product’s demand in the forthcoming years. Postponement of Green Investment by Government amid COVID-19 to Hamper Growth According to Capgemini Research Institute, out of the 300 large energy companies surveyed in October 2020, 37% planned to postpone investments in low-carbon projects and infrastructure amid the novel coronavirus. The pandemic has dented the growth prospects of several industries across the globe. Postponement or halting of several projects is expected to hamper the growth prospects of the global market. What does the Report Include? The global market for bioplastics report includes qualitative and quantitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies to announce partnerships, introduce new products, and collaborate to further contribute to the growth of the market between 2021 and 2028. Moreover, the research analyst has adopted several research methodologies to extract information about the current trends and industry developments that will drive the market growth during the forecast period. DRIVING FACTORS Increasing Demand for Eco-Friendly Plastics to Aid Growth According to the data by Clean our Ocean, annually plastic is estimated to kill around millions of marine animals across the globe. The growing concern over plastic disposal is propelling the demand for eco-friendly variants of plastics such as biodegradable ones. The biggest recipient of this type of plastic is the packaging industry. The increasing adoption of environment-friendly plastics that serve as a rigid and flexible packaging option is expected to boost the product’s adoption worldwide. Therefore, the growing concerns over the disposal of non-degradable plastics will contribute to the global bioplastics market growth in the forthcoming years. Browse Summary: https://www.fortunebusinessinsights.com/industry-reports/bioplastics-market-101940

The global Inertial Measurement Unit (IMU) Market size is projected to reach USD 24.91 billion by 2027, exhibiting a CAGR of 9.22% during the forecast period. The inertial measurement unit (IMU) market refers to the industry that produces and sells IMUs, which are electronic devices that measure and report a body's specific force, angular rate, and sometimes the magnetic field surrounding the body, using a combination of accelerometers, gyroscopes, and magnetometers. IMUs are used in a wide range of applications, including aerospace, navigation, robotics, automotive, and consumer electronics. The global IMU market has been growing steadily over the past few years and is expected to continue to grow in the coming years. Factors driving the growth of the IMU market include the increasing demand for IMUs in the aerospace and defense sectors, the rising adoption of automation and robotics in various industries, and the growing demand for consumer electronics such as smartphones and wearables. Information Source: https://www.fortunebusinessinsights.com/industry-reports/inertial-measurement-unit-market-101827 Market Driver There are several drivers contributing to the growth of the inertial measurement unit (IMU) market. Some of the key drivers include: Increasing demand from the aerospace and defense sector: IMUs are extensively used in aerospace and defense applications, such as aircraft, missiles, and unmanned aerial vehicles (UAVs). With the increasing demand for advanced defense systems and commercial aircraft, the demand for IMUs is also growing. Adoption of automation and robotics: The adoption of automation and robotics is increasing in various industries, such as automotive, manufacturing, and healthcare. IMUs are used in these industries to provide accurate information about the position and motion of objects, which is essential for the functioning of these systems. Growing demand for consumer electronics: IMUs are a critical component in consumer electronics such as smartphones, wearables, and gaming devices. The increasing demand for these devices is driving the demand for IMUs. Advancements in MEMS technology: The advancements in micro-electromechanical systems (MEMS) technology have led to the development of smaller, lighter, and more accurate IMUs. These advancements are making IMUs more accessible and affordable, which is driving the growth of the market. Increasing demand for autonomous vehicles: IMUs are used in autonomous vehicles to provide information about the vehicle's motion and orientation. With the increasing demand for autonomous vehicles, the demand for IMUs is also growing. Regional Insights North America to Lead the Charge; Asia-Pacific to Register Steady Growth North America, with a market size of USD 6.70 billion in 2019, is poised to dominate the inertial measurement unit market share during the forecast period owing to the strong presence of IMU manufacturers in the region. Moreover, the US is the highest defense spender in the world and is known to use some of the most advanced weaponry and surveillance technologies. These factors provide the necessary fodder for the growth of this market in the region. On the other hand, the market size in Asia-Pacific is anticipated to expand steadily on account of rising military spending in India and China. Other than this, the region is also experiencing surging usage of smartphones and other consumer electronics, which are the critical factors favoring market growth in the region. Competitive Landscape Growing Investment in R&D by Companies to Intensify Competition Development of IMUs requires innovation in engineering techniques and therefore, most players in this market are ramping up their R&D investment to enhance their innovation capabilities. This is also enabling them to strengthen their position in this market, diversify their portfolio, and expand globally. Industry Developments: January 2020: The Japanese electronics company, TDK Corporation, launched a family of inertial measurement units called InvenSense, featuring high performance and fault-tolerance capacities. Conceived for industrial applications, the novel offerings can measure three dimensions of rotation rate and three dimensions of linear acceleration. September 2019: Honeywell International, the US-based conglomerate, released HGuide, the company’s new world-class, lightweight, and low-cost IMU. The product is designed to withstand any environmental condition and caters to several application areas, including transportation, UAVs, surveying and mapping, robotics, and agriculture.

Analysis of TCR Therapy market Strategies and Forecasts to 2035 Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications Roots Analysis is pleased to announce the publication of its recent study, titled, “Global TCR-based Therapy Market (2nd Edition), 2022-2035.” The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of TCR- based therapies.  An analysis of the popular target antigens related to hematological malignancies and solid tumors.  A detailed analysis of completed, ongoing and planned clinical studies related to TCR-based therapies.  An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TCR-based therapies.  Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above).  An analysis of various type of partnership that have been inked between several stakeholders in the domain of TCR-based therapies.  An analysis of the investments that have been made into companies that have proprietary TCR-based products / technologies.  An in-depth analysis of patents related to TCR-based therapies, filed / granted till 2022.  A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.  An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.  A review of the key promotional strategies being adopted by the developers of the approved TCR-based therapies.  Elaborate profiles of the several leading players in the domain of TCR cell therapies. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Target Indication(s)  Nasopharyngeal Carcinoma  Multiple Myeloma  Head and Neck Carcinoma  Sarcoma, Melanoma  Acute Myeloid Leukemia  Lung Cancer  Ovarian Cancer  Merkel Cell Cancer  Target Antigen  NY-ESO-1  EBV  gp100  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Vincent Brichard (Vice President, Immuno-Oncology, Celyad)  Adrian Bot (Vice President, Scientific Affairs, Kite Pharma)  Victor Lietao Li (Co-Founder and Chief Executive Officer, Lion TCR)  Miguel Forte (Former Chief Operating Officer, TxCell) The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about TCR-based product(s), such as information on type of therapy and current development status, information on technology portfolio (if available), recent developments related to TCR therapy and manufacturing capabilities of the players.  Adaptimmune Therapeutics  Alaunos Therapeutics  Bristol Myers Squibb  Cellular Biomedicine Group  Gilead Sciences  GlaxoSmithKline  Immatics  Immunocore  Lion TCR  Takara Bio  Zelluna Immunotherapy To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/tcr-based-therapies-market.html You may also be interested in the following titles: Oral Solid Dosage Manufacturing Market Lipid Nanoparticles in Drug Delivery You may also like to learn what our experts are sharing in Roots educational series: Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities Adeno-Associated Viral Vectors: Unlocking the Future Opportunities About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #TCRTherapyMarketSize #TCRTherapyMarketTrends #TCRimmunotherapies #TCRbasedproducts #TCRTherapy